Decode Age
PrivateLast Round
Pre Seed
Dec 17, 2025
Est. Valuation
$5.35M
Total Funding Raised
$1.96M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Decode Age operates in Healthcare & Life Sciences and is based in Bangalore. Its latest recorded funding round was a Pre Seed round in December 2025.
Decode Age is a biotechnology company that provides longevity supplements, diagnostic tests, and wellness products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Precision Medicine, Subscription Commerce
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Decode Age Comparables
Compare Decode Age with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DoNotAge | 78% | |
| Leucine Rich Bio | 78% | |
| NOVOS | 77% |
For institutional investors. Book with your work email.
Decode Age Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Dec 17, 2025 | ||||
| Angel | Feb 12, 2024 | ||||
| Seed | Jul 29, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Decode Age Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NineSpar Partners LLP | Seed |
| IVY Growth Associates | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 72% MoM.
- Jul 16, 2026
ERP system integrated with D2C and B2B Shopify stores.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesAug 12, 2026
Decode Age launches Mag7 in Mar '26, a magnesium supplement combining seven forms, including bisglycinate, malate, taurate and citrate, with Aquamin and the liposomal delivery ingredient Lipoza.
For institutional investors. Book with your work email.
Decode Age Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Decode Age's valuation, stock price, and market status.
Is Decode Age a public or private company?
Decode Age is a private company.
What is the current stock price of Decode Age?
Decode Age is a private company, so its shares have no public market price. Caplight tracks Decode Age's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Decode Age worth (valuation)?
Decode Age's valuation is estimated at $5.3M based on funding round data.
Can I buy Decode Age stock?
Decode Age shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Decode Age's last funding round?
Decode Age's most recent funding round was Pre Seed on December 17, 2025.
Who are the main investors in Decode Age?
Key investors in Decode Age include NineSpar Partners LLP, IVY Growth Associates.
Will Decode Age IPO soon?
No public IPO plans have been announced for Decode Age.
How can I track Decode Age secondary market activity?
Caplight tracks bids, offers, and trades in Decode Age's shares on secondary markets.